Cleared Traditional

K131199 - ULTRAVERSE RX PTA BALLOON DILATATION CATHETER (FDA 510(k) Clearance)

May 2013
Decision
34d
Days
Class 2
Risk

K131199 is an FDA 510(k) clearance for the ULTRAVERSE RX PTA BALLOON DILATATION CATHETER. This device is classified as a Catheter, Angioplasty, Peripheral, Transluminal (Class II - Special Controls, product code LIT).

Submitted by Bard Peripheral Vascular, Inc. (Tempe, US). The FDA issued a Cleared decision on May 30, 2013, 34 days after receiving the submission on April 26, 2013.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1250.

Submission Details

510(k) Number K131199 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 26, 2013
Decision Date May 30, 2013
Days to Decision 34 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code LIT — Catheter, Angioplasty, Peripheral, Transluminal
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1250

Similar Devices — LIT Catheter, Angioplasty, Peripheral, Transluminal

All 9
Armada™ 14 NC PTA Catheter
K252512 · Abbott Medical · Feb 2026
Passeo-35 Xeo Peripheral Dilatation Catheter
K250706 · Biotronik, Inc. · Apr 2025
Oscar Peripheral Multifunctional Catheter system
K241711 · Biotronik, Inc. · Jul 2024
Sterling™ MONORAIL™ PTA Balloon Dilatation Catheter (H74939031404020 )
K241683 · Boston Scientific Corporation · Jul 2024
Passeo-35 Xeo Peripheral Dilatation Catheter
K222065 · Biotronik, Inc. · Feb 2023
Highlander™ 014 PTA Balloon Dilatation Catheter
K223177 · C.R. Bard, Inc. · Jan 2023